Sign in

CIK 0001515673

  • Large accelerated filer

Ultragenyx Pharmaceutical Inc.

Sign in to watch
Ticker
RARE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
272546083
Phone
+1 415-483-8800
Business address
60 LEVERONI COURT, NOVATO, CA, 94949
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$127,561
in 3 filings, $17K under 10b5-1 plans

Net −$127,561. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-03-01 Bedrosian Camille L EVP and Chief Medical Officer Grant or award +5,634 37,549
2020-03-01 Bedrosian Camille L EVP and Chief Medical Officer Shares withheld for taxes −1,249 $56.08 $70K 36,300
2020-03-01 Bedrosian Camille L EVP and Chief Medical Officer Grant or award · Stock Option (Right to Buy) +21,000 21,000
2020-01-30 Bedrosian Camille L EVP and Chief Medical Officer Shares withheld for taxes −1,624 $53.23 $86K 24,615
2020-01-14 Huizenga Theodore Alan SVP, Controller and PAO Sale −1,000 $61.00 $61K 15,946
2019-10-14 Harris Erik EVP & Chief Commercial Officer Grant or award +1,208 14,309
2019-10-14 Huang Dennis Karl EVP & Chief Tech Ops Officer Grant or award +1,434 23,579
2019-10-14 KAKKIS EMIL D President & CEO Grant or award +3,435 475,914
2019-10-14 Kassberg Thomas Richard CBO & EVP Grant or award +1,434 91,675
2019-10-14 Parschauer Karah Herdman EVP and General Counsel Grant or award +1,434 19,084
2019-10-14 Pinion John Richard Grant or award +1,434 39,138
2019-10-14 Sharp Shalini CFO & Executive Vice President Grant or award +1,434 100,523

Page 32 of 32 · 632 trades